Jones, A., Cohen-Barak, O., Radivojevic, A., & Fiedler-Kelly, J. (2021). Scaling Approaches for Pediatric Dose Selection: The Fremanezumab (AJOVY(®)) Journey to Select a Phase 3 Dose Using Pharmacokinetic Data from a Phase 1 Study. Pharmaceutics.
Citação norma ChicagoJones, Aksana, Orit Cohen-Barak, Andrijana Radivojevic, and Jill Fiedler-Kelly. "Scaling Approaches for Pediatric Dose Selection: The Fremanezumab (AJOVY(®)) Journey to Select a Phase 3 Dose Using Pharmacokinetic Data From a Phase 1 Study." Pharmaceutics 2021.
ציטוט MLAJones, Aksana, Orit Cohen-Barak, Andrijana Radivojevic, and Jill Fiedler-Kelly. "Scaling Approaches for Pediatric Dose Selection: The Fremanezumab (AJOVY(®)) Journey to Select a Phase 3 Dose Using Pharmacokinetic Data From a Phase 1 Study." Pharmaceutics 2021.